These outcomes, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the notion of concentrating on ACKR3 as a unique way to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Is